Arkolith/Insider Trading/FATE/Form 4

Redmile Group, LLC

Director, 10% OwnerFATE THERAPEUTICS INC (FATE) · full profile →Form 4 · filed Dec 28, 2023
Net Buying
Open-Market Buys
$166K
Open-Market Sells
$0
Net Open-Market Flow
$166K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 26, 2023Buy(P)45K$3.72$166K13.2M
Dec 26, 2023Other(J)1.7M$3.72$6.2M13.1M
Dec 26, 2023Other(J)1.7M$3.72$6.2M13.1M

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-130203) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML